I Took Magic Mushrooms to Reverse Aging (The Results)
Summary
Psilocybin therapy and anti-aging research intersect in a self-administered clinical experiment evaluating the impact of high-dose psilocybin on physiological longevity markers. After reviewing cell culture studies suggesting psilocybin extends human cellular lifespan, Bryan Johnson designed a protocol tracking 249 biomarkers across brain activity, inflammation, metabolism, hormones, and the gut microbiome. Two controlled high-dose sessions (4.67 g and 5.35 g of dried B+ psilocybin mushrooms) revealed measurable biological shifts. Morning cortisol levels dropped by 42%, DHEA dropped by 45%, and systemic inflammation (hs-CRP) decreased below detection limits. Continuous glucose monitoring showed an 8% drop in mean blood sugar and an 11% reduction in glucose variability. Neuroimaging with Kernel Flow demonstrated increased brain entropy and heightened sensory connectivity during the trips, followed by cumulative neuroplastic changes. The results suggest psilocybin may act as a systemic longevity intervention by resetting stress response pathways and metabolic systems.